Penaja kami

Kami tidak menerima pembiayaan komersial atau konflik - ini adalah penting supaya kami boleh menjana maklumat yang berwibawa dan boleh dipercayai, yang dihasilkan oleh orang yang boleh bekerja secara bebas, tanpa kawalan oleh kepentingan komersil dan kewangan.

Model pembiayaan Cochrane mencerminkan sifat antarabangsa dan sebaran organisasi. Pendapatan teras kami (pendapatan yang dibayar terus kepada Cochrane dan digunakan untuk mengekalkan sistem pengurusan maklumat, program penyelidikan, laman web dan lain-lain) datang terutamanya daripada hasil Perpustakaan Cochrane dan lain-lain produk Cochrane, kumpulan kami juga disokong oleh kerajaan kebangsaan dan antarabangsa, organisasi bukan kerajaan, universiti, hospital, yayasan swasta dan sumbangan peribadi.Mereka tidak dibenarkan menerima dana daripada organisasi komersil seperti syarikat farmaseutikal. Ini adalah untuk memastikan kesimpulan Ulasan Cochrane tidak dipengaruhi oleh kepentingan komersil.

Baca lebih lanjut mengenai dasar kami pada penajaan komersial.

Cochrane ingin mengucapkan terima kasih kepada yang berikut atas sokongan mereka:

Lebih daripada £ 1 juta

  • National Institute for Health Research (UK)
  • National Institutes of Health (USA)
  • Den danske regering/The Danish Government (Rigshospitalet Research Committee) (Denmark)

£ 500K hingga 1 juta

  • Bill & Melinda Gates Foundation (USA)
  • National Health and Medical Research Council (Australia)

£ 100K hingga 500K

  • Bundesministerium für Gesundheit/Federal Ministry of Health (Germany)
  • Canadian Institutes of Health Research (Canada)
  • Centre Hospitalier Universitaire Vaudois (Switzerland)
  • Chief Scientist Office (Scotland)
  • Department for Health and Human Services Victoria (Australia)
  • Department for International Development (UK)
  • European Commission
  • Finnish Institute of Occupational Health (Finland)
  • Hospital de la Santa Creu i Sant Pau (Spain)
  • HSC Research and Development (Northern Ireland)
  • Kika  Kinderen kanker vrij (Netherlands)
  • Medical Research Council (South Africa)
  • Ministère des affaires sociales et de la santé/Ministry of Social Affairs and Health (France)
  • National Centre for Child Health and Development (Japan)
  • National Evidence-based Healthcare Collaborating Agency (Republic of Korea)
  • National Institute for Health and Welfare (Finland)
  • New Zealand Ministry of Health (New Zealand)
  • Norwegian Agency for Development Cooperation (Norway)
  • Patient Centered Outcomes Research Institute (PCORI) (USA)
  • Universität Freiburg (Germany)
  • Pertubuhan Kesihatan Sedunia

£ 50K hingga 100K

  • Agency for Healthcare Research and Quality (USA)
  • British Association (UK)
  • British Association of Oral and Maxillofacial Surgeons (UK)
  • Bundesministerium für Bildung und Forschung/Federal Ministry of Education and Research (Germany)
  • Cardiovascular Assocation Centroccidental/Asociacion Cardiovascular Centroccidental –Ascardio (Venezuela)
  • Deutsche Krebshilfe e.V./German Cancer Aid (Germany)
  • Fundación Saldarriaga-Concha (Columbia)
  • Good Ventures (USA)
  • Health Research Board (Ireland)
  • Hospital São Paulo (Brazil)
  • Japan Agency for Medical Research and Development (Japan)
  • Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong (Hong Kong)
  • Julius Center, University Medical Center, Utrecht (Netherlands)
  • Liverpool School of Tropical Medicine (UK)
  • Lower Austrian Health and Social Fund (Austria)
  • Mayo Clinic (USA)
  • Ministerio de Salud y Proteccion Social (Colombia)
  • Ministry of Health (Austria)
  • Ministry of Health and Welfare (Taiwan)
  • National Center for Dental Hygiene Research & Practice (USA)
  • National Research Foundation of Korea (Republic of Korea)
  • New York University College of Dentistry (USA)
  • Singapore Clinical Research Institute (Singapore)
  • Suva (Switzerland)

£ 20K hingga 50K

  • Asociación Cardiovascular Centroccidental (Venzuela)
  • Assistance Publique, Hopitaux de Paris (France)
  • Departamento Administrativo de Ciencia tecnología e Innovación-Colciencias (Columbia)
  • Evidence-based Discipline from Universidade Federal de São Paulo (Brazil)
  • Faculdade de Medicina de Lisboa (Portugal)
  • Fondazione Italiana Sclerosi Multipla/Italian Multiple Sclerosis Foundation (Italy)
  • Institut National du Cancer (France)
  • Instituto Nacional de Salud (Peru)
  • Ministerio de Sanidad, Servicios Sociales e Igualdad (Spain)
  • Ministero della Salute/Italian Health Ministry (Italy)
  • Pontificia Universidad Javeriana (Colombia)
  • Taipei Medical University (Taiwan)
  • The Joanna Briggs Institute (Australia)
  • Universidade Federal de São Paulo (Brazil)
  • University of Pécs (Hungary)

£ 10K hingga 20K

  • A.R.E.M.A.N - Association for Epidemiological Research for Neurological Diseases (Italy)
  • CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível/Superior Funding Agency for Research (Brazil)
  • Colombian Association of Gastroenterology (Colombia)
  • Department of Translational Surgery and Medicine, University of Florence (Italy)
  • Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen/Institute for Quality and Efficiency in Health Care (Germany)
  • Instituto Ramón y Cajal de Investigación Sanitaria (Spain)
  • KFPE - Swiss Commission for Research Partnerships with Developing Countries (Switzerland)
  • MDS Foundation (Portugal)
  • Ministry of Science and Higher Education (Poland)
  • National Breast Cancer Foundation (Australia)
  • Pontificia Universidad Católica de Chile (Chile)
  • Sanita Regione Umbria/Region of Umbria, Health Authority (Italy)
  • State of Lower Austria (Austria)
  • Swiss Academy of Medical Sciences (Switzerland)
  • Swiss School of Public Health (Switzerland)
  • Universidad Nacional de Colombia (Colombia)
  • University of Johannesburg (South Africa)
  • WHO - Policy Buddies through Stellenbosch University (South Africa)

Di bawah £ 10K

  • Agenzia Sanitaria e Sociale Regionale - Emilia-Romagna (Italy)
  • AREAS - CCI/Associazione per la Ricerca sulla Efficacia della Assistenza Sanitaria - Centro Cochrane Italiano (Italy)
  • Cabrini Institute (Australia)
  • Coeliac Australia (Australia)
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
  • Federale Overheids Dienst (FOD) Volksgezondheid - Federal Public Service Public Health (Belgium)
  • Food and Safety Australia and New Zealand (New Zealand)
  • French Society of Dermatologie (SFD)
  • Fundación de ciencias de la salud (Colombia)
  • Grad Split / City of Split / City of Zagreb (Croatia)
  • Health Media Ltd (New Zealand)
  • Hospital Infantil de México Federico Gómez (Mexico)
  • Hospital Pediátrico de Sinaloa (Mexcio)
  • IHCAI FOUNDATION-International Health Central American Institute Foundation (Costa Rica)
  • Institute for Medical Research (Malaysia)
  • Jagiellonian University Medical College (Poland)
  • Manipal University, Manipal, Karnataka (India)
  • Melaka-Manipal Medical College (Malaysia)
  • Ministry of Health Republic & Science and Technology Secretariat of Cuba (Cuba)
  • Ministry of Science, Education and Sports (Croatia)
  • Minneapolis Veteran's Administration Medical Center (USA)
  • Motor Neurone Disease Association (UK)
  • NHS Blood and Transplant, McMaster University (Canada) 
  • Odense Universitetshospital (Odense University Hospital) (Denmark)
  • OSyddansk Universitet (University of Southern Denmark) (Denmark)
  • Otago University (New Zealand)
  • Peruvian Ministry of Health (Peru)
  • Société Française de Médecine d'Urgence/French Society of Emergency Physicians (France)
  • Sveučilište u Splitu/University of Split, School of Medicine (Croatia)
  • Universiti Sains Malaysia (Malaysia)
  • University of Auckland (New Zealand)
  • University of Minnesota (USA)
  • West China Hospital (China)
Berkongsi/Menyimpan